Plain-English translation of NCT06384313 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a butyrate-enriched triglyceride oil—a specially designed supplement—to see if it can help prevent type 2 diabetes in people who are at high risk. The oil contains two compounds (butyrate and hexanoate) that early research suggests may help your body control blood sugar better, reduce inflammation, and improve how your body uses insulin. Half of the participants will receive the active oil, and half will receive a placebo (inactive oil) to compare results.
Animal studies and early human research suggest that butyrate and hexanoate can help your body control weight, reduce inflammation, and improve insulin sensitivity. However, we don't yet know whether taking this medication regularly over a longer period actually prevents diabetes or improves health in people at real risk—that's what this study aims to find out.
You likely qualify if…
You likely don't qualify if…
You will take a daily dose of either the active oil or placebo oil for the duration of the study. You will attend clinic visits where researchers will measure your blood sugar levels, insulin resistance, weight, and other markers of metabolic health to see whether the treatment is helping. The study involves basic blood tests and monitoring to track changes in your body's ability to control blood sugar over time.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Netherlands